DrugDashboards

Ketalar

ketamine hydrochloride · KETAMINE HYDROCHLORIDE 10 mg/mL · Injection · Intramuscular; Intravenous · Par Health USA, LLC

NDC 42023-0113-10 · 10 VIAL in 1 CARTON / 20 mL in 1 VIAL · NDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$197.82
Reported to Texas DSHS · 2026 annual filing · Par Health USA, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$13,162
1,834 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for ketamine hydrochloride (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA016812
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of ketamine hydrochloride (Injection)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationKETAMINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.KETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.KETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCKETAMINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCKETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCKETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCKETAMINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, IncKETAMINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.KETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCKETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026
Par Health USA, LLCKETAMINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Par Health USA, LLCKETAMINE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Par Health USA, LLCKETAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ketalar — NDC 42023-0113-10," retrieved September 3, 2026, https://drugdashboards.com/drug/42023011310.

Free to cite with attribution — see how the data is put together.